HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 202 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2023. The put-call ratio across all filers is 0.36 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,664,224 | -3.0% | 264,395 | +4.2% | 0.00% | 0.0% |
| Q2 2023 | $8,933,227 | +5.0% | 253,857 | -2.6% | 0.00% | 0.0% |
| Q1 2023 | $8,507,610 | -43.6% | 260,570 | -4.8% | 0.00% | -33.3% |
| Q4 2022 | $15,077,398 | +26.4% | 273,637 | +1.6% | 0.00% | 0.0% |
| Q3 2022 | $11,933,000 | +7.7% | 269,402 | +18.6% | 0.00% | 0.0% |
| Q2 2022 | $11,077,000 | +4.8% | 227,122 | +4.5% | 0.00% | +50.0% |
| Q1 2022 | $10,572,000 | +24.3% | 217,304 | +9.0% | 0.00% | 0.0% |
| Q4 2021 | $8,503,000 | +223.6% | 199,411 | +190.9% | 0.00% | +100.0% |
| Q3 2021 | $2,628,000 | +106.1% | 68,553 | +51.8% | 0.00% | – |
| Q2 2021 | $1,275,000 | +195.1% | 45,146 | +245.2% | 0.00% | – |
| Q1 2021 | $432,000 | +5.9% | 13,077 | +15.7% | 0.00% | – |
| Q4 2020 | $408,000 | – | 11,298 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $618,113,619 | 97.50% |
| venBio Partners LLC | 1,035,396 | $57,050,320 | 17.69% |
| Vivo Capital, LLC | 2,606,247 | $143,604 | 16.53% |
| Nan Fung Group Holdings Ltd | 368,665 | $20,313,442 | 14.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $14,560,725 | 4.50% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 685,340 | $37,762,234 | 3.51% |
| ASHFORD CAPITAL MANAGEMENT INC | 356,638 | $19,650,754 | 3.05% |
| TANG CAPITAL MANAGEMENT LLC | 281,200 | $15,494,120 | 2.25% |
| MPM BioImpact LLC | 139,377 | $7,679,673 | 1.99% |
| O'Neil Global Advisors, Inc. | 7,335 | $404 | 1.86% |